All In MedTech

FDA Clearance Tracker · P240003-S006

Minima Pro Stent System

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Jul 9, 2026 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Jul 9, 2026

Approved

Time to decision

198 days

Received Dec 23, 2025. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P240003-S006
Device name
Minima Pro Stent System
Applicant location
Newport Beach, CA
Received
Dec 23, 2025
Decided
Jul 9, 2026
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P240003

Device type

Device class
Class III

Every decision under product code PNF

FDA's approval statement

As written in FDA's record.

Approval for design modifications and a line extension to the Minima Stent System, including a stent design change from closed cell to hybrid open-cell, a new 10mm balloon size for expansion of the stent, delivery system design changes, and packaging design changes. The device, as modified, will be marketed under the trade name Minima Pro Stent System.

Source documents

Other decisions for Renata Medical, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.